Literature DB >> 27649481

Dynamic contrast-enhanced MRI of the prostate: An intraindividual assessment of the effect of temporal resolution on qualitative detection and quantitative analysis of histopathologically proven prostate cancer.

Justin M Ream1, Ankur M Doshi1, Diane Dunst1, Nainesh Parikh1, Max X Kong2, James S Babb1, Samir S Taneja3, Andrew B Rosenkrantz1.   

Abstract

PURPOSE: To assess the effects of temporal resolution (RT ) in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) on qualitative tumor detection and quantitative pharmacokinetic parameters in prostate cancer.
MATERIALS AND METHODS: This retrospective Institutional Review Board (IRB)-approved study included 58 men (64 ± 7 years). They underwent 3T prostate MRI showing dominant peripheral zone (PZ) tumors (24 with Gleason ≥ 4 + 3), prior to prostatectomy. Continuously acquired DCE utilizing GRASP (Golden-angle RAdial Sparse Parallel) was retrospectively reconstructed at RT of 1.4 sec, 3.7 sec, 6.0 sec, 9.7 sec, and 14.9 sec. A reader placed volumes-of-interest on dominant tumors and benign PZ, generating quantitative pharmacokinetic parameters (ktrans , ve ) at each RT . Two blinded readers assessed each RT for lesion presence, location, conspicuity, and reader confidence on a 5-point scale. Data were assessed by mixed-model analysis of variance (ANOVA), generalized estimating equation (GEE), and receiver operating characteristic (ROC) analysis.
RESULTS: RT did not affect sensitivity (R1all : 69.0%-72.4%, all Padj  = 1.000; R1GS≥4 + 3 : 83.3-91.7%, all Padj  = 1.000; R2all : 60.3-69.0%, all Padj  = 1.000; R2GS≥4 + 3 : 58.3%-79.2%, all Padj  = 1.000). R1 reported greater conspicuity of GS ≥ 4 + 3 tumors at RT of 1.4 sec vs. 14.9 sec (4.29 ± 1.23 vs. 3.46 ± 1.44; Padj  = 0.029). No other tumor conspicuity pairwise comparison reached significance (R1all : 2.98-3.43, all Padj ≥ 0.205; R2all : 2.57-3.19, all Padj ≥ 0.059; R1GS≥4 + 3 : 3.46-4.29, all other Padj ≥ 0.156; R2GS≥4 + 3 : 2.92-3.71, all Padj ≥ 0.439). There was no effect of RT on reader confidence (R1all : 3.17-3.34, all Padj  = 1.000; R2all : 2.83-3.19, all Padj ≥ 0.801; R1GS≥4 + 3 : 3.79-4.21, all Padj  = 1.000; R2GS≥4 + 3 : 3.13-3.79, all Padj  = 1.000). ktrans and ve of tumor and benign tissue did not differ across RT (all adjusted P values [Padj ] = 1.000). RT did not significantly affect area under the curve (AUC) of Ktrans or ve for differentiating tumor from benign (all Padj  = 1.000).
CONCLUSION: Current PI-RADS recommendations for RT of 10 seconds may be sufficient, with further reduction to the stated PI-RADS preference of RT ≤ 7 seconds offering no benefit in tumor detection or quantitative analysis. LEVEL OF EVIDENCE: 3 J. MAGN. RESON. IMAGING 2017;45:1464-1475.
© 2016 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  dynamic-contrast enhanced MRI; prostate; tumor detection

Mesh:

Substances:

Year:  2016        PMID: 27649481      PMCID: PMC5538355          DOI: 10.1002/jmri.25451

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  43 in total

1.  Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: Assessment at an optimal threshold.

Authors:  Andrew B Rosenkrantz; Alampady K Shanbhogue; Annie Wang; Max Xiangtian Kong; James S Babb; Samir S Taneja
Journal:  J Magn Reson Imaging       Date:  2015-09-23       Impact factor: 4.813

2.  Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology.

Authors:  Thomas E Yankeelov; William D Rooney; Wei Huang; Jonathan P Dyke; Xin Li; Alina Tudorica; Jing-Huei Lee; Jason A Koutcher; Charles S Springer
Journal:  NMR Biomed       Date:  2005-05       Impact factor: 4.044

Review 3.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

Review 4.  Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.

Authors:  Nola Hylton
Journal:  J Clin Oncol       Date:  2006-07-10       Impact factor: 44.544

5.  Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

Authors:  Cher Heng Tan; Brian Paul Hobbs; Wei Wei; Vikas Kundra
Journal:  AJR Am J Roentgenol       Date:  2015-04       Impact factor: 3.959

6.  Temporal sampling requirements for the tracer kinetics modeling of breast disease.

Authors:  E Henderson; B K Rutt; T Y Lee
Journal:  Magn Reson Imaging       Date:  1998-11       Impact factor: 2.546

7.  Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis.

Authors:  J Ren; Y Huan; H Wang; Y-J Chang; H-T Zhao; Y-L Ge; Y Liu; Y Yang
Journal:  Clin Radiol       Date:  2007-11-19       Impact factor: 2.350

8.  Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging.

Authors:  M O Leach; B Morgan; P S Tofts; D L Buckley; W Huang; M A Horsfield; T L Chenevert; D J Collins; A Jackson; D Lomas; B Whitcher; L Clarke; R Plummer; I Judson; R Jones; R Alonzi; T Brunner; D M Koh; P Murphy; J C Waterton; G Parker; M J Graves; T W J Scheenen; T W Redpath; M Orton; G Karczmar; H Huisman; J Barentsz; A Padhani
Journal:  Eur Radiol       Date:  2012-05-07       Impact factor: 5.315

Review 9.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

10.  Zone-specific logistic regression models improve classification of prostate cancer on multi-parametric MRI.

Authors:  Nikolaos Dikaios; Jokha Alkalbani; Mohamed Abd-Alazeez; Harbir Singh Sidhu; Alex Kirkham; Hashim U Ahmed; Mark Emberton; Alex Freeman; Steve Halligan; Stuart Taylor; David Atkinson; Shonit Punwani
Journal:  Eur Radiol       Date:  2015-02-14       Impact factor: 5.315

View more
  3 in total

1.  Population net benefit of prostate MRI with high spatiotemporal resolution contrast-enhanced imaging: A decision curve analysis.

Authors:  Vinay Prabhu; Andrew B Rosenkrantz; Ricardo Otazo; Daniel K Sodickson; Stella K Kang
Journal:  J Magn Reson Imaging       Date:  2019-01-10       Impact factor: 4.813

2.  Assessment of the compliance with minimum acceptable technical parameters proposed by PI-RADS v2 guidelines in multiparametric prostate MRI acquisition in tertiary referral hospitals in the Republic of Turkey.

Authors:  Mehmet Coşkun; Ali Fırat Sarp; Şebnem Karasu; Mustafa Fazıl Gelal; Barış Türkbey
Journal:  Diagn Interv Radiol       Date:  2019-11       Impact factor: 2.630

3.  Diagnostic Performance of PI-RADS v2, Proposed Adjusted PI-RADS v2 and Biparametric Magnetic Resonance Imaging for Prostate Cancer Detection: A Preliminary Study.

Authors:  Guan-Hui Cai; Qi-Hua Yang; Wen-Bo Chen; Qing-Yu Liu; Yu-Rong Zeng; Yu-Jing Zeng
Journal:  Curr Oncol       Date:  2021-05-12       Impact factor: 3.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.